drugset / Trial / NCT04331327

Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis

NCT04331327 ↗

Phase 2 Completed 31 enrolled Rasmia Elgohary
RandomizedParallel-groupOpen-labelTreatment

Summary

the study was conducted on 31-patients with symptomatic primary knee osteoarthritis. The patients were randomized into intervention and control groups. The control group was kept on their medications without intervention. The intervention group received two doses of allogenic lyophilized growth factors (L-GFs); at baseline and after 2 months.

Timeline

Start
2017-05-01
Primary completion
2018-04-28
Completion
2018-04-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator allogenic lyophilized growth factors Protein / enzyme biologic — Other

Indications